Hualan Biological Engineering Inc - Class A

1
SZSE:002007 (China)   Class A
Â¥ 17.79 (-1.33%) Jun 7
23.35
P/B:
2.80
Market Cap:
Â¥ 32.53B ($ 4.49B)
Enterprise V:
Â¥ 29.32B ($ 4.05B)
Volume:
10.55M
Avg Vol (2M):
11.44M
Volume:
10.55M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Hualan Biological Engineering Inc ( ) from 2004 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hualan Biological Engineering stock (SZSE:002007) PE ratio as of Jun 09 2024 is 23.35. More Details

Hualan Biological Engineering Inc (SZSE:002007) PE Ratio (TTM) Chart

To

Hualan Biological Engineering Inc (SZSE:002007) PE Ratio (TTM) Historical Data

Total 1201
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Hualan Biological Engineering PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-09 23.4 2024-04-01 26.1
2024-06-07 23.4 2024-03-29 26.5
2024-06-06 23.7 2024-03-28 26.0
2024-06-05 24.1 2024-03-27 23.9
2024-06-04 23.9 2024-03-26 24.2
2024-06-03 23.7 2024-03-25 24.1
2024-05-31 23.9 2024-03-22 24.1
2024-05-30 24.6 2024-03-21 24.5
2024-05-29 24.1 2024-03-20 24.8
2024-05-28 24.3 2024-03-19 24.9
2024-05-27 24.1 2024-03-18 25.1
2024-05-24 24.3 2024-03-15 25.2
2024-05-23 24.7 2024-03-14 25.2
2024-05-22 25.0 2024-03-13 25.5
2024-05-21 25.1 2024-03-12 25.7
2024-05-20 26.3 2024-03-11 24.6
2024-05-17 25.8 2024-03-08 23.8
2024-05-16 25.7 2024-03-07 23.7
2024-05-15 26.0 2024-03-06 24.2
2024-05-14 26.5 2024-03-05 24.4
2024-05-13 25.8 2024-03-04 24.5
2024-05-10 26.2 2024-03-01 24.4
2024-05-09 26.0 2024-02-29 24.3
2024-05-08 25.6 2024-02-28 23.9
2024-05-07 25.9 2024-02-27 24.3
2024-05-06 26.0 2024-02-26 24.0
2024-04-30 25.6 2024-02-23 24.1
2024-04-29 25.5 2024-02-22 24.1
2024-04-26 24.3 2024-02-21 23.7
2024-04-25 25.0 2024-02-20 23.7
2024-04-24 25.1 2024-02-19 23.5
2024-04-23 25.0 2024-02-08 23.4
2024-04-22 25.3 2024-02-07 23.3
2024-04-19 25.0 2024-02-06 22.9
2024-04-18 24.8 2024-02-05 21.7
2024-04-17 25.0 2024-02-02 21.7
2024-04-16 24.8 2024-02-01 21.9
2024-04-15 24.9 2024-01-31 21.7
2024-04-12 24.7 2024-01-30 22.3
2024-04-11 24.4 2024-01-29 22.9
2024-04-10 24.5 2024-01-26 23.2
2024-04-09 24.9 2024-01-25 23.4
2024-04-08 24.6 2024-01-24 22.8
2024-04-03 25.5 2024-01-23 22.8
2024-04-02 25.8 2024-01-22 22.3

Hualan Biological Engineering Inc (SZSE:002007) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Hualan Biological Engineering Inc
NAICS : 541711 SIC : 2836
ISIN : CNE000001JN8

Share Class Description:

SZSE:002007: Class A
Description
Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.